Delivery Order SPE2DB20D2002-SPE2DB25FL73H
- Not listed
- The Defense Logistics Agency awarded a $1,968.89 delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL quantities. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 5, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,383.41 by the Defense Logistics Agency on August 28, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL cartridges. The contract is a firm fixed price delivery order with no set-aside designation, reflecting competitive award to the vendor. Performance will be completed at the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 29, 2025. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,022.80 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin in 3ml quantities. This firm fixed price, competitively awarded contract was issued on July 22, 2025, with an ultimate completion date of July 23, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order represents a single transaction executed...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Lantus SoloStar insulin (100 unit/mL, 3mL formulation) with a ceiling value of $1,022.80. This is a firm fixed-price delivery order issued without set-aside designation, indicating competitive award to the vendor. The contract is to be completed by August 21, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,006.73 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL insulin in 3mL quantities. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and utilizes firm fixed price pricing with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/mL 3mL insulin, valued at $1,845.94 under a firm fixed price contract. The award, issued on September 10, 2025, with an ultimate completion date of September 11, 2025, represents a non-competitive delivery order executed without set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, fulfilled this order from its corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Lantus SoloStar 100 unit/mL insulin in 3 mL cartridges, with a contract ceiling value of $4,634.22. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award status. The order is set to complete by September 2, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency has awarded a delivery order valued at $1,965.00 to AmerisourceBergen Drug Corp for the supply of Lantus SoloStar 100 Unit/ML insulin, with a completion date of August 21, 2025. This is a firm fixed price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor's corporate office in Conshohocken, Pennsylvania, where the company is headquartered. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $7,444.34 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lantus SoloStar insulin (100 units/mL, 3mL formulation) with an ultimate completion date of July 28, 2025. This non-set-aside contract represents a competitive award to the Conshohocken, Pennsylvania-based pharmaceutical distributor, reflecting DLA's ongoing procurement of critical medical supplies for military and federal healthcare systems. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Lantus SoloStar 100 Unit/ML insulin in 3 mL formulations. This firm fixed-price delivery order, valued at $1,333.80, represents a non-set-aside competitive award and is part of AmerisourceBergen's broader relationship with DLA. The contract carries an ultimate completion date of August 22, 2025, with performance to be executed at AmerisourceBergen's corporate headquarters in...
- SPE2DB20D2002Indefinite Delivery Contract
- SPE2DB20D2002-SPE2DB25FL73HDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,889.55 to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Lantus SoloStar 100 Unit/mL insulin in 3 mL cartridges. This firm fixed-price delivery order, which is non-competitive set-aside, is scheduled for completion by September 4, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The contract represents a pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 comprehensive global pharmaceutical support vehicle running through December 2026. As a prime pharmaceutical distributor and critical vendor for federal healthcare systems, AmerisourceBergen supplies medications and medical supplies to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The delivery of Lantus insulin through this established contract vehicle demonstrates the company's role in providing essential pharmaceutical commodities to federal customers on a firm fixed-price basis.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 9/3/25 |